Methylation of promoter sequences in SDC2, SFRP1, SFRP2, and proline rich membrane anchor 1 (PRIMA1) was observed in 85.1%, 72.3%, 89.4%, and 80.9% of plasma samples from CRC patients, respectively. This evidence concerns the gene PRIMA1 and colorectal carcinoma.